Published in Redox Biol on September 10, 2015
Effects of portulacerebroside a on apoptosis of human leukemia HL60 cells and p38/JNK signaling pathway. Int J Clin Exp Pathol (2015) 0.77
Effects of the IGF-1/PTEN/Akt/FoxO signaling pathway on male reproduction in rats subjected to water immersion and restraint stress. Mol Med Rep (2016) 0.75
Albendazole as a promising molecule for tumor control. Redox Biol (2016) 0.75
Water extract of Galla Rhois with steaming process enhances apoptotic cell death in human colon cancer cells. Integr Med Res (2016) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (1997) 10.90
Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol (2010) 9.06
Targeting metabolic transformation for cancer therapy. Nat Rev Cancer (2010) 5.90
Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol (2006) 5.68
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood (2008) 4.61
Chronic lymphocytic leukemia. N Engl J Med (1995) 4.52
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med (2011) 3.58
Mitochondrial energetics and therapeutics. Annu Rev Pathol (2010) 3.07
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62
Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer (2010) 2.08
Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell (2001) 2.02
Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 1.99
Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest (2005) 1.91
Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal (2009) 1.89
Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta (2002) 1.54
Mitochondrial pharmacology. Trends Pharmacol Sci (2012) 1.51
Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res (2003) 1.49
The permeability transition pore complex in cancer cell death. Oncogene (2006) 1.47
Apoptosis and molecular targeting therapy in cancer. Biomed Res Int (2014) 1.47
Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene (2000) 1.45
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology (2005) 1.41
Modulatory effects of polyphenols on apoptosis induction: relevance for cancer prevention. Int J Mol Sci (2008) 1.29
Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol Immunother (2011) 1.28
Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells. Blood (2006) 1.15
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res (2005) 1.15
The treatment of relapsed refractory chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program (2011) 1.14
Novel agents for chronic lymphocytic leukemia. J Hematol Oncol (2013) 1.12
Chronic lymphocytic leukemia. Crit Rev Oncol Hematol (2007) 1.10
Even free radicals should follow some rules: a guide to free radical research terminology and methodology. Free Radic Biol Med (2014) 1.09
Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Blood (2004) 1.06
Evasion of apoptosis as a cellular stress response in cancer. Int J Cell Biol (2010) 1.04
The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res (2010) 1.01
Therapeutic advancement of chronic lymphocytic leukemia. J Hematol Oncol (2012) 0.98
Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med (2014) 0.98
Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration. Iran J Pharm Res (2014) 0.94
A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia. Cancer Res (2009) 0.94
Mitochondria-penetrating peptides: sequence effects and model cargo transport. Chembiochem (2009) 0.93
Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria. Biomed Res Int (2014) 0.88
Mitochondria: a promising target for anticancer alkaloids. Curr Top Med Chem (2013) 0.87
Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies. Biochim Biophys Acta (2012) 0.87
Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity. Cell Death Differ (2007) 0.84
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study. Leuk Lymphoma (2009) 0.82
ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells. Int J Oncol (2012) 0.80
Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia. Blood Rev (2015) 0.80